Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer

Fusheng Wang is the trial’s principal investigator. Fusheng Wang, Yonggang Li, Z Xu and Yuanyuan Li conceptualized the study and designed its methods. Yonggang Li, Z Xu, Yuanyuan Li, T Jiang, F Meng, J Fu and L Huang recruited participants and performed clinical procedures. Fusheng Wang, Yonggang Li, Z Xu, Yuanyuan Li, Fengchao Wang and X Wang analyzed the data, interpreted the results and drafted the manuscript. All authors revised and reviewed the manuscript and contributed to the final approval of the manuscript.

Comments (0)

No login
gif